1. The prognostic genes model of breast cancer drug resistance based on single-cell sequencing analysis and transcriptome analysis

   • Yao Liu
   • Lun Dong
   • Zhibiao Wang

   Research Open access 25 May 2024 Article: 113

   

2. Establishment of a neutrophil extracellular trap-related prognostic signature for colorectal cancer liver metastasis and expression validation of CYP4F3

   • Xiao-Li Tang
   • Zi-Yang Xu
   • Zheng-Yun Zhang

   Research Open access 25 May 2024 Article: 112

   

3. The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab

   • Akihiro Yoshimura
   • Akira Nagahara
   • Taigo Kato

   Research Open access 23 May 2024 Article: 111

   

4. The diagnostic value of multimodal imaging based on MR combined with ultrasound in benign and malignant breast diseases

   • Dong Bai
   • Nan Zhou
   • Zhiqun Wang

   Research Open access 23 May 2024 Article: 110

   

5. Iloprost infusion reduces serological cytokines and hormones of hypoxia and inflammation in systemic sclerosis patients

   • Chiara Pellicano
   • Amalia Colalillo
   • Edoardo Rosato

   Research Open access 22 May 2024 Article: 109

   

6. The effect of bone marrow mesenchymal stromal cell exosomes on acute myeloid leukemia’s biological functions: a focus on the potential role of LncRNAs

   • Sahar Jalilivand
   • Mehrdad Izadirad
   • Sina Naserian

   Research Open access 22 May 2024 Article: 108

   

7. The clinical significance of TAT, PIC, TM, and t-PAIC in vascular events of BCR/ABL-negative myeloproliferative neoplasms

   • Kangle Huang
   • Qiuyu Mo
   • Ping Lei

   Research Open access 22 May 2024 Article: 107

   

8. Immunophenotype of myeloid granulocytes in Chinese patients with BCR::ABL1-negative myeloproliferative neoplasms

   • Fengting Liang
   • Xuelan Liang
   • Xiuhua Chen

   Research Open access 21 May 2024 Article: 106

   

9. Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy

   • Naokazu Nakamura
   • Tomoyasu Jo
   • Akifumi Takaori-Kondo

   Research Open access 21 May 2024 Article: 105

   

10. An exosomes-related lncRNA prognostic model correlates with the immune microenvironment and therapy response in lung adenocarcinoma

    • Daifang Chu
    • Liulin Chen
    • Haitao Zhang

    Research Open access 18 May 2024 Article: 104

    

11. Cardioprotective effects of vaccination in hospitalized patients with COVID-19

    • Julian Madrid
    • Prerana Agarwal
    • Esther Askani

    Research Open access 17 May 2024 Article: 103

    

12. IFN-α/β/IFN-γ/IL-15 pathways identify GBP1-expressing tumors with an immune-responsive phenotype

    • Lei Wang
    • Yuxuan Wei
    • Qian Chu

    Research Open access 17 May 2024 Article: 102

    

13. MUC16: clinical targets with great potential

    • Xin-Yu Zhang
    • Lian-Lian Hong
    • Zhi-qiang Ling

    Review Open access 17 May 2024 Article: 101

    

14. Epidemiology of malignant tumors in patients with pemphigus: an analysis of trends from 1955 to 2021

    • Yue Luo
    • Xiaoya Fei
    • Jiankun Song

    Review Open access 17 May 2024 Article: 100

    

15. CD3, CD8, IFN-γ, tumor and stroma inflammatory cells as prognostic indicators for surgically resected SCLC: evidences from a 10-year retrospective study and immunohistochemical analysis

    • Meng Fu
    • Chunmei Feng
    • Hongzhi Wang

    Research Open access 15 May 2024 Article: 99

    

16. Mast cells in human choroid and their role in age-related macular degeneration (AMD)

    • Domenico Ribatti
    • Rosanna Dammacco

    Correspondence Open access 10 May 2024 Article: 98

17. Safety of Janus kinase inhibitors compared to biological DMARDs in patients with rheumatoid arthritis and renal impairment: the ANSWER cohort study

    • Yoichi Nakayama
    • Akira Onishi
    • Akio Morinobu

    Research Open access 10 May 2024 Article: 97

    

18. The titers of antinuclear antibodies are associated with the degree of inflammation and organ damage in Primary Sjögren's Syndrome

    • Huijun Shao
    • Yue Wu
    • Jinhui Tao

    Research Open access 08 May 2024 Article: 96

    

19. Enhancing multiple myeloma staging: a novel cell death risk model approach

    • Zeyu Deng
    • Hongkai Zhu
    • Hongling Peng

    Research Open access 08 May 2024 Article: 95

    

20. Immune cell signatures and inflammatory mediators: unraveling their genetic impact on chronic kidney disease through Mendelian randomization

    • Yongzheng Hu
    • Fengyun Hao
    • Wei Jiang

    Research Open access 04 May 2024 Article: 94

    

21. Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors

    • Xiao-Ping Fu
    • Chun-Yan Ji
    • Lei Luo

    Review Open access 02 May 2024 Article: 93

    

22. Molecular characterization of m6A RNA methylation regulators with features of immune dysregulation in IgA nephropathy

    • Yihao Wang
    • Nan Sun
    • Junwen Qu

    Research Open access 02 May 2024 Article: 92

    

23. Inclusion body myositis, viral infections, and TDP-43: a narrative review

    • Vitalie Văcăraş
    • Romana Vulturar
    • Laura Damian

    Review Open access 02 May 2024 Article: 91

    

24. Therapeutic potential of third-generation chimeric antigen receptor T cells targeting B cell maturation antigen for treating multiple myeloma

    • Punchita Rujirachaivej
    • Teerapong Siriboonpiputtana
    • Pa-thai Yenchitsomanus

    Research Open access 29 April 2024 Article: 90

    

25. High PPP4C expression predicts poor prognosis in diffuse large B-cell lymphoma

    • Xue Hui
    • Liru Li
    • Yue Zhang

    Research Open access 29 April 2024 Article: 89

    

26. Risk factors for severe COVID-19 infection and the impact of COVID-19 infection on disease progression among patients with AAV

    • Chen Wang
    • Zhi-Ying Li
    • Min Chen

    Research Open access 29 April 2024 Article: 88

27. Infectious complications in pediatric patients undergoing CD19+CD22+ chimeric antigen receptor T-cell therapy for relapsed/refractory B-lymphoblastic leukemia

    • Xiaochen Wu
    • Zhanmeng Cao
    • Benshang Li

    Research Open access 25 April 2024 Article: 87

    

28. A novel diagnostic model based on lncRNA PTPRE expression, neutrophil count and red blood cell distribution width for diagnosis of seronegative rheumatoid arthritis

    • Jinfang Xia
    • Huali Gao
    • Jinpiao Lin

    Research Open access 25 April 2024 Article: 86

    

29. miR-17-92a-1 cluster host gene: a key regulator in colorectal cancer development and progression

    • Amirhossein Mohajeri Khorasani
    • Samane Mohammadi
    • Pegah Mousavi

    Review Open access 25 April 2024 Article: 85

    

30. Fibroblast expression of neurotransmitter receptor HTR2A associates with inflammation in rheumatoid arthritis joint

    • Chunyan Xiang
    • Soon-Min Hong
    • Runci Wang

    Research Open access 25 April 2024 Article: 84

    

31. Extrachromosomal circular DNA (eccDNA): from carcinogenesis to drug resistance

    • Zhaoxing Li
    • Daohai Qian

    Review Open access 25 April 2024 Article: 83

    

32. Improving quality of life after breast cancer: a comparison of two microsurgical treatment options for breast cancer-related lymphedema (BCRL)

    • Katrin Seidenstuecker
    • Sonia Fertsch
    • Elisabeth A. Kappos

    Research Open access 23 April 2024 Article: 82

    

33. Does the SARS-CoV-2 mRNA vaccine and its serum IgG levels affect fertility treatments and obstetric outcomes? An observational cohort study

    • Netanella Danielli Miller
    • Nitzan Goren Gepstein
    • Amir Wiser

    Research Open access 23 April 2024 Article: 81

    

34. Genomic characterization and detection of potential therapeutic targets for peritoneal mesothelioma in current practice

    • Job P. van Kooten
    • Michelle V. Dietz
    • Jan H. von der Thüsen

    Research Open access 20 April 2024 Article: 80

    

35. Exploring natural killer cell-related biomarkers in multiple myeloma: a novel nature killer cell-related model predicting prognosis and immunotherapy response using single-cell study

    • Jing Zhao
    • Xiaoning Wang
    • Wenjuan Zhu

    Research Open access 18 April 2024 Article: 79

    

36. Comparison of trace elements in peripheral blood and bone marrow of newly diagnosed multiple myeloma patients

    • Ayse Nilgun Kul
    • Bahar Ozturk Kurt

    Research Open access 17 April 2024 Article: 78

37. Clinical impact of transient lymphopenia

    • Luigi Petramala
    • Cinzia Milito
    • Claudio Letizia

    Research Open access 17 April 2024 Article: 77

    

38. Genetic alterations and allele frequency of BRAF V600E and TERT mutation in papillary thyroid carcinoma with intermediate-to-high recurrence risk: a retrospective study

    • Jiayu Huang
    • Jiazhi Wang
    • Yongfu Zhao

    Research Open access 12 April 2024 Article: 76

    

39. The prevalence of chronic obstructive pulmonary disease in patients with spondyloarthritis compared to the general population in the southernmost region of Sweden: a case–control study

    • Petros Zamout
    • Sofia Exarchou
    • Carl Turesson

    Research Open access 10 April 2024 Article: 75

40. A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers

    • Anna Barbato
    • Fabiola Piscopo
    • Pietro Carotenuto

    Research Open access 10 April 2024 Article: 74

    

41. Supporting the decision to perform molecular profiling for cancer patients based on routinely collected data through the use of machine learning

    • Julia Kasprzak
    • C. Benedikt Westphalen
    • Daniel Nasseh

    Research Open access 10 April 2024 Article: 73

    

42. Antinuclear antibodies may predict the development of immune-related adverse events in asymptomatic patients treated with immune checkpoint inhibitors: results from a single-center cohort

    • Fulvia Ceccarelli
    • Francesco Natalucci
    • Fabrizio Conti

    Research Open access 10 April 2024 Article: 72

    

43. Retraction Note: Angiopoietin4 (ANGPT4) expression and potential mechanisms in carcinogenesis: current achievements and perspectives

    • Wen-chao Zhou
    • Qun-feng Zhang
    • Juan Zou

    Retraction Note 06 April 2024 Article: 71

44. Low platelet count at diagnosis of anti-neutrophil cytoplasmic antibody-associated vasculitis is correlated with the severity of disease and renal prognosis

    • Yanli Jin
    • Fangyuan Wang
    • Xiaozhao Li

    Research Open access 05 April 2024 Article: 70

    

45. Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies

    • Valentina Giudice
    • Monica Ianniello
    • Carmine Selleri

    Research Open access 05 April 2024 Article: 69

    

46. Letermovir prophylaxis for cytomegalovirus in lung-transplant recipients: a comprehensive study with literature review of off-label use and real-world experiences

    • Takashi Hirama
    • Yuki Shundo
    • Yoshinori Okada

    Research Open access 05 April 2024 Article: 68

47. Investigation of long non-coding RNAs in extracellular vesicles from low-volume blood serum specimens of colorectal cancer patients

    • Marie Boudna
    • Tana Machackova
    • Ondrej Slaby

    Research Open access 03 April 2024 Article: 67

    

48. Clinical features and prognosis of ANCA-associated vasculitis patients who were double-seropositive for myeloperoxidase-ANCA and proteinase 3-ANCA

    • Yizi Gong
    • Chanjuan Shen
    • Yong Zhong

    Research Open access 02 April 2024 Article: 66

    

49. The casual relationship between autoimmune diseases and multiple myeloma: a Mendelian randomization study

    • Peipei Jin
    • Xiaoqing Jin
    • Zhuo Zhan

    Research Open access 02 April 2024 Article: 65

    

50. Development and validation of a novel prognostic nomogram for advanced diffuse large B cell lymphoma

    • Mengdi Wan
    • Wei Zhang
    • Tongyu Lin

    Research Open access 30 March 2024 Article: 64